Skip to main content

SELLAS Life Sciences Group, Inc (SLS) Stock

SELLAS Life Sciences Group, Inc Stock Details, Movements and Public Alerts

Stock Details

SELLAS Life Sciences Group, Inc (SLS), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NCM.Currently, the stock is trading at $14.23. Over the past 52 weeks, it has ranged between $1.39 and $15.88. This places the current price at 89.6% of its 52-week high and 923.7% above its 52-week low. Recent trading volume was recorded at 3,545. The 14-day Relative Strength Index (RSI) stands at 66.71, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $7.97 by 78.54%. Similarly, it is above its 200-day moving average of $4.42 by 221.95%. The MACD histogram is 0.53, indicating bullish momentum (MACD Line: 1.84, Signal Line: 1.30). There are currently 2 active alerts set for SLS by users.

52-Week Range

$15.88 - $1.39

-10.39% from high · +923.74% from low

Avg Daily Volume

10,811,987

20-day average

100-day avg: 8,208,701

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-92.93

Price to Book

23.55

EPS (TTM)

-$0.23

Beta

2.42

More volatile than market

Q:How is SLS valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is SLS's risk profile compared to the market?
With a beta of 2.42, SELLAS Life Sciences Group, Inc is significantly more volatile than the market. For every 10% market move, this stock tends to move 24% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 23.55 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

Return on Equity

-43.59%

Return on Assets

-25.45%

Q:How profitable and efficient is SLS's business model?
Profitability metrics are not available for this stock.
Q:What are SLS's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$2.7B

Shares Outstanding

196.63M

Book Value/Share

$0.59

Asset Type

EQUITY

Q:What is SLS's market capitalization and position?
SELLAS Life Sciences Group, Inc has a market capitalization of $2.7B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 196.63M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does SLS's price compare to its book value?
SELLAS Life Sciences Group, Inc's book value per share is $0.59, while the current stock price is $14.23, resulting in a price-to-book (P/B) ratio of 24.04. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$10.00

29.73% downside potential

Analyst Recommendations

Strong Buy

1

Buy

2

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for SLS?
3 analysts cover SLS with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $10.00 implies -29.7% downside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on SLS?
Current analyst recommendations:1 Strong Buy, 2 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jul 7, 2026, 02:07 AM

Technical Indicators

RSI (14-day)

66.71

Neutral

50-Day Moving Average

$7.97

78.54% above MA-50

200-Day Moving Average

$4.42

221.95% above MA-200

MACD Line

1.84

MACD Signal

1.30

MACD Histogram

0.53

Bullish

Q:What does SLS's RSI value tell investors?
The RSI (Relative Strength Index) for SLS is currently 66.71, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret SLS's MACD and moving average crossovers?
MACD analysis shows the MACD line at 1.84 above the signal line at 1.30, with histogram at 0.53. This bullish crossover suggests upward momentum is building. The 50-day MA ($7.97) is above the 200-day MA ($4.42), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Jul 7, 2026, 12:57 AM

Active Alerts

Alert Condition
Price decreases by
Threshold
7%
Created
Jun 12, 2026, 04:22 PM
Alert Condition
Golden Cross
Threshold
N/A
Created
Jan 26, 2026, 09:04 AM

Stay Ahead of the Market with SELLAS Life Sciences Group, Inc Alerts

Set up price alerts for SELLAS Life Sciences Group, Inc and get notified instantly when the price hits your target. Never miss an important price movement again.